Randomized trial · people

Mazdutide beat dulaglutide on HbA1c and weight at 28 weeks

Checked against the paper Randomized trialPublished by PepVault

The takeaway

In this head-to-head trial, mazdutide lowered blood sugar and weight more than dulaglutide 1.5 mg over 28 weeks, with more stomach and gut side effects.

Kind
Randomized trial
Studied in
People
Number studied
731
Published
2026
Journal
Nature

What they tested

The team tested whether weekly mazdutide controls blood sugar and body weight better than dulaglutide in adults with type 2 diabetes already on diabetes pills.

How the study was done

A randomized phase III trial in 731 Chinese adults with type 2 diabetes who stayed on their usual oral diabetes drugs. Participants were split evenly among the 4 mg mazdutide arm, the 6 mg mazdutide arm and the 1.5 mg dulaglutide arm for 28 weeks.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

Model. Individual results vary.

PepVault for iPhone

Taking mazdutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

Both mazdutide arms lowered HbA1c (a long-term average of blood sugar) more than dulaglutide, with a treatment difference of -0.24% in the 4 mg arm (P = 0.0032) and -0.30% in the 6 mg arm (P = 0.0003). Weight dropped more too, with a treatment difference of -3.78% for the 4 mg arm and -5.76% for the 6 mg arm versus dulaglutide (both P < 0.0001). More people on either mazdutide dose reached both an HbA1c under 7.0% and at least 5% weight loss by week 28 (both P < 0.0001). Diarrhea, nausea and vomiting were the most common side effects, and stomach and gut side effects were more frequent with mazdutide than with dulaglutide.

What it doesn’t show

The trial ran for 28 weeks and included only Chinese adults with type 2 diabetes, so it does not show longer-term results or how other groups respond. It compared mazdutide with one dulaglutide dose, not with other diabetes or weight medicines.

The paper

Guo et al. Mazdutide versus dulaglutide in Chinese adults with type 2 diabetes. Nature. 2026.

The compounds

More studies on Mazdutide

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking mazdutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo